A large-scale 19F MRI-based cell migration assay to optimize cell therapy

NMR in Biomedicine

Volumn 25, Issue 9, 2012, Pages 1095-1103

  Bonetto, F ^a,b,c   Srinivas, M ^b   Weigelin, B ^a   Cruz, L J ^a   Heerschap, A ^b   Friedl, P ^a   Figdor, C G ^a   de Vries, I J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

19F MRI; Cell migration; Dendritic cell immunotherapy; Migration assays; Quantification

Indexed keywords

CELL DELIVERY; CELL DENSITY; CELL FUNCTIONS; CELL MIGRATION; CELL NUMBER; CELL THERAPY; CHEMOKINES; CLINICAL USE; COLLAGEN SCAFFOLDS; DENDRITIC CELLS; IMMUNE RESPONSE; IN-VITRO ASSAYS; IN-VIVO; LYMPH NODE; QUANTIFICATION; QUANTITATIVE ASSAY; TARGET ORGANS; TARGET TISSUES; TISSUE SAMPLES;

ASSAYS; CELLS; CYTOLOGY; OPTIMIZATION; TISSUE;

SCAFFOLDS (BIOLOGY);

CHEMOKINE; SCAFFOLD PROTEIN;

ARTICLE; BOLUS INJECTION; CELL COUNT; CELL DENSITY; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; DENDRITIC CELL; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REACTION OPTIMIZATION; THREE DIMENSIONAL IMAGING;

CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL TRANSPLANTATION; DENDRITIC CELLS; FLUORINE; HUMANS; MAGNETIC RESONANCE IMAGING; STAINING AND LABELING;

EID: 84865293371     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2774     Document Type: Article

References (40)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
2. Reis e Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006; 6: 476-483.
3. Aarntzen EH, Figdor CG, Adema GJ, Punt CJ, de Vries IJ. Dendritic cell vaccination and immune monitoring. Cancer Immunol. Immunother. 2008; 57(10): 1559-1568.
4. Banchereau J, Palucka A. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005; 5: 296-306.
5. Lesterhuis WJ, de Vries IJ, Adema GJ, Punt CJ. Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results. Ann. Oncol. 2004; 15(Suppl. 4): iv145-iv151.
6. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature 2007; 449(7161): 419-426.
7. De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003; 63(1): 12-17.
8. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 2005; 23(11): 1407-1413.
9. Srinivas M, Aarntzen EH, Bulte JW, Oyen WJ, Heerschap A, de Vries IJ, Figdor CG. Imaging of cellular therapies. Adv. Drug Deliv. Rev. 2010; 62(11): 1080-1093.
10. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat. Med. 2004; 10: 475-480.
11. Verdijk P, Aarntzen EH, Punt CJ, de Vries IJ, Figdor CG. Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin. Biol. Ther. 2008; 8(7): 865-874.
12. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods 2005; 37(2): 208-215.
13. Schimmelpfennig CH, Schulz S, Arber C, Baker J, Tarner I, McBride J, Contag CH, Negrin RS. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. Am. J. Pathol. 2005; 167: 1321-1331.
14. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI. Fluorine-18 labeled mouse bone marrow derived dendritic cells can be detected in vivo by high resolution projection imaging. J. Immunol. Methods 2002; 260: 137-148.
15. Prince HM, Wall DM, Ritchie D, Honemann D, Harrrison S, Quach H, Thompson M, Hicks R, Lau E, Davison J, Loudovaris M, Moloney J, Loveland B, Bartholeyns J, Katsifis A, Mileshkin L. In vivo tracking of dendritic cells in patients with multiple myeloma. J. Immunother. 2008; 31: 166-179.
16. Eggert AA, van der Voort R, Torensma R, Moulin V, Boerman OC, Oyen WJ, Punt CJ, Diepstra H, de Boer AJ, Figdor CG, Adema GJ. Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol. Lett. 2003; 89: 17-24.
17. Mackensen A, Krause T, Blum U, Uhrmeister P, Mertelsmann R, Lindemann A. Homing of intravenously and intralymphatically injected human dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells. Cancer Immunol. Immun. 1999; 48: 118-122.
18. Noh Y, Lim YT, Chung BH. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J. 2008; 22: 3908-3918.
19. Sen D, Deerinck TJ, Ellisman MH, Parker I, Cahalan MD. Quantum dots for tracking dendritic cells and priming an immune response in vitro and in vivo. PLoS One 2008; 3(9): e3290.
20. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 2005; 23(8): 983-987.
21. Baumjohann D, Hess A, Budinsky L, Brune K, Schuler G, Lutz MB. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice. Eur. J. Immunol. 2006; 36: 2544-2555.
22. 19F tracer agent for in vivo tracking of human dendritic cell vaccines. Cytotherapy 2010; 12: 238-250.
23. Verdijk P, Scheenen TW, Lesterhuis WJ, Gambarota G, Veltien AA, Walczak P, Scharenborg NM, Bulte JW, Punt CJ, Heerschap A, Figdor CG, de Vries IJ. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int. J. Cancer 2007; 120(5): 978-984.
24. Ruiz-Cabello J, Walczak P, Kedziorek DA, Chacko VP, Schmieder AH, Wickline SA, Lanza GM, Bulte JW. In vivo 'hot spot' MR imaging of neural stem cells using fluorinated nanoparticles. Magn. Reson. Med. 2008; 60(6): 1506-1511.
25. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 2007; 58(4): 725-734.
26. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, Ahrens ET. In vivo cytometry of antigen-specific T cells using (19)F MRI. Magn. Reson. Med. 2009; 62: 747-753.
27. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010; 28: 363-370.
28. 19F MRI and optical imaging. Biomaterials 2010; 31: 7070-7077.
29. Friedl P, Brocker EB. The biology of cell locomotion within three-dimensional extracellular matrix. Cell. Mol. Life Sci. 2000; 57: 41-64.
30. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84: 359-369.
31. Petrie RJ, Doyle AD, Yamada KM. Random versus directionally persistent cell migration. Nat. Rev. Mol. Cell Biol. 2009; 10: 538-549.
32. Even-Ram S, Yamada KM. Cell migration in 3D matrix. Curr. Opin. Cell Biol. 2005; 17: 524-532.
33. Demou ZN, McIntire LV. Fully automated three-dimensional tracking of cancer cells in collagen gels: determination of motility phenotypes at the cellular level. Cancer Res. 2002; 62: 5301-5307.
34. Friedl P, Noble PB, Zanker KS. Lymphocyte locomotion in three-dimensional collagen gels. Comparison of three quantitative methods for analysing cell trajectories. J. Immunol. Methods 1993; 165: 157-165.
35. Niggemann B, Drell TL, Joseph J, Weidt C, Lang K, Zaenker KS, Entschladen F. Tumor cell locomotion: differential dynamics of spontaneous and induced migration in a 3D collagen matrix. Exp. Cell Res. 2004; 298: 178-187.
36. Verdijk P, Aarntzen EH, Lesterhuis WJ, Boullart AC, Kok E, van Rossum MM, Strijk S, Eijckeler F, Bonenkamp JJ, Jacobs JF, Blokx W, Vankrieken JH, Joosten I, Boerman OC, Oyen WJ, Adema G, Punt CJ, Figdor CG, de Vries IJ. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin. Cancer Res. 2009; 15(7): 2531-2540.
37. Boullart AC, Aarntzen EH, Verdijk P, Jacobs JF, Schuurhuis DH, Benitez-Ribas D, Schreibelt G, van de Rakt MW, Scharenborg NM, de Boer A, Kramer M, Figdor CG, Punt CJ, Adema GJ, de Vries IJ. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration. Cancer Immunol. Immunother. 2008; 57(11): 1589-1597.
38. Friedl P, Brocker EB. Reconstructing leukocyte migration in 3D extracellular matrix by time-lapse videomicroscopy and computer-assisted tracking. In Methods in Molecular Biology, Vol. 239. D'Ambrosio D, Sinigaglia F (eds). Humana Press: New York; 2003, pp. 77-90.
39. Kadayakkara D, Janjic J, Pusateri L, Young W-B, Ahrens ET. In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn. Reson. Med. 2010; 64: 1252-1259.
40. Decaestecker C, Debeir O, Van Ham P, Kiss R. Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitativeanalysis of cell migration. Med. Res. Rev. 2007; 27: 149-176.